TRCT
CRTX

Tower Research Capital (TRC)’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-800
Closed -$8K – 5499
2013
Q4 		$8K Buy
800
+37
+5% +$350 ﹤0.01% 3265
2013
Q3 		$7K Buy
+763
New +$6.88K ﹤0.01% 3510

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Tower Research Capital (TRC)'s CRTX Position: Q1 2014 in Review

Tower Research Capital (TRC) sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 800 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in CRTX in Q3 2013 and held it in 2 quarters. The position peaked at $8K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Tower Research Capital (TRC) reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 800 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $8K.
  • Tower Research Capital (TRC) first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s CORNERSTONE THERAPEUTICS INC position peaked at $8K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2014, filed 2 May 2014.